DUBLIN--(BUSINESS WIRE)--Mainstay Medical today announced that the United States Centers for Disease Control and Prevention (CDC) has designated an International Classification of Diseases, Tenth ...

A new study carried out by researchers at Concordia’s School of Health provides a new way of looking at the spine. The research reveals the way one spinal muscle’s size, shape and function relates to ...

Mainstay Medical Holdings plc has won U.S. FDA approval for its Reactiv8 implantable neurostimulation device. The company is eyeing a commercial launch of the system in early 2021. The FDA approved ...